This post was originally published on this site
https://i-invdn-com.akamaized.net/news/LYNXNPEF150TG_M.jpg
Eli Lilly announced earnings per share of $1.75 on revenue of $5.86B. Analysts polled by Investing.com anticipated EPS of $1.48 on revenue of $5.46B. That with comparison to EPS of $1.33 on revenue of $5.09B in the same period a year before. Eli Lilly had reported EPS of $1.73 on revenue of $6.11B in the previous quarter. Analysts are expecting EPS of $1.66 and revenue of $5.94B in the upcoming quarter.
Eli Lilly shares are up 19% from the beginning of the year , still down 2.17% from its 52 week high of $160.19 set on April 20. They are outperforming the S&P 500 which is down 13.73% year to date.
Eli Lilly’s report follows an earnings beat by J&J on April 14, who reported EPS of $2.3 on revenue of $20.69B, compared to forecasts EPS of $2.02 on revenue of $19.73B.
Abbott Labs had beat expectations on April 16 with first quarter EPS of $0.65 on revenue of $7.73B, compared to forecast for EPS of $0.59 on revenue of $7.44B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
